Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial

Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects. The present study evaluated the effect of atorvastatin added to interferon beta-1b in multiple sclerosis (MS) in a multicenter, randomized, parallel-group, rater-blinded study performed in eight Swi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamm, Christian Philipp, El-Koussy, Marwan, Humpert, Sebastian, Findling, Oliver, von Bredow, Ferdinand, Burren, Yuliya, Schwegler, Guido, Schött, Dagmar, Donati, Filippo, Müller, Martin, Goebels, Norbert, Müller, Felix, Slotboom, Johannes, Tettenborn, Barbara, Kappos, Ludwig, Naegelin, Yvonne, Mattle, Heinrich Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484273/
https://www.ncbi.nlm.nih.gov/pubmed/22569835
http://dx.doi.org/10.1007/s00415-012-6513-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484273/
https://www.ncbi.nlm.nih.gov/pubmed/22569835
http://dx.doi.org/10.1007/s00415-012-6513-7

Ejemplares similares